Correlation Between Avax Techs and OncoVista Innovative
Can any of the company-specific risk be diversified away by investing in both Avax Techs and OncoVista Innovative at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avax Techs and OncoVista Innovative into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avax Techs and OncoVista Innovative Therapies, you can compare the effects of market volatilities on Avax Techs and OncoVista Innovative and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avax Techs with a short position of OncoVista Innovative. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avax Techs and OncoVista Innovative.
Diversification Opportunities for Avax Techs and OncoVista Innovative
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Avax and OncoVista is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Avax Techs and OncoVista Innovative Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoVista Innovative and Avax Techs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avax Techs are associated (or correlated) with OncoVista Innovative. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoVista Innovative has no effect on the direction of Avax Techs i.e., Avax Techs and OncoVista Innovative go up and down completely randomly.
Pair Corralation between Avax Techs and OncoVista Innovative
Given the investment horizon of 90 days Avax Techs is expected to under-perform the OncoVista Innovative. But the stock apears to be less risky and, when comparing its historical volatility, Avax Techs is 1.87 times less risky than OncoVista Innovative. The stock trades about -0.04 of its potential returns per unit of risk. The OncoVista Innovative Therapies is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 0.01 in OncoVista Innovative Therapies on November 2, 2024 and sell it today you would earn a total of 0.01 from holding OncoVista Innovative Therapies or generate 100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Avax Techs vs. OncoVista Innovative Therapies
Performance |
| Timeline |
| Avax Techs |
| OncoVista Innovative |
Avax Techs and OncoVista Innovative Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Avax Techs and OncoVista Innovative
The main advantage of trading using opposite Avax Techs and OncoVista Innovative positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avax Techs position performs unexpectedly, OncoVista Innovative can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoVista Innovative will offset losses from the drop in OncoVista Innovative's long position.The idea behind Avax Techs and OncoVista Innovative Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| OncoVista Innovative vs. Cyclacel Pharmaceuticals | OncoVista Innovative vs. Amylyx Pharmaceuticals | OncoVista Innovative vs. Axsome Therapeutics | OncoVista Innovative vs. Exelixis |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |